Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2127-2134
Published online before print September 13, 2007, doi: 10.1161/ATVBAHA.107.143149
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
27/10/2127    most recent
ATVBAHA.107.143149v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sone, M.
Right arrow Articles by Nakao, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sone, M.
Right arrow Articles by Nakao, K.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2127.)
© 2007 American Heart Association, Inc.


Vascular Biology

Pathway for Differentiation of Human Embryonic Stem Cells to Vascular Cell Components and Their Potential for Vascular Regeneration

Masakatsu Sone; Hiroshi Itoh; Kenichi Yamahara; Jun K. Yamashita; Takami Yurugi-Kobayashi; Akane Nonoguchi; Yutaka Suzuki; Ting-Hsing Chao; Naoki Sawada; Yasutomo Fukunaga; Kazutoshi Miyashita; Kwijun Park; Naofumi Oyamada; Naoya Sawada; Daisuke Taura; Naohisa Tamura; Yasushi Kondo; Shinji Nito; Hirofumi Suemori; Norio Nakatsuji; Shin-Ichi Nishikawa; Kazuwa Nakao

From the Department of Medicine and Clinical Science (M.S., H.I., K.Y., T.Y-K., A.N., T-H.C., Naok.S., Y.F., K.M., K.P., N.O., Naoy.S., D.T., N.T., K.N.), Kyoto University Graduate School of Medicine, Kyoto, Japan; Department of Internal Medicine (H.I.), Keio University School of Medicine, Tokyo, Japan; Laboratory of Stem Cell Differentiation (J.K.Y.) and Laboratory of Embryonic Stem Cell Research (H.S.), Stem Cell Research Center, and Department of Development and Differentiation (N.N.), Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan; Discovery Research Laboratory (Y.S., Y.K., S.N.), Tanabe Seiyaku Co, Ltd, Osaka, Japan; Center for Developmental Biology (S-I.N.), RIKEN, Kobe, Japan.

Correspondence to Hiroshi Itoh, Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan. E-mail hiito{at}kuhp.kyoto-u.ac.jp

Objective— We demonstrated previously that mouse embryonic stem (ES) cell–derived vascular endothelial growth factor receptor-2 (VEGF-R2)–positive cells can differentiate into both vascular endothelial cells and mural cells. This time, we investigated kinetics of differentiation of human ES cells to vascular cells and examined their potential as a source for vascular regeneration.

Methods and Results— Unlike mouse ES cells, undifferentiated human ES cells already expressed VEGF-R2, but after differentiation, a VEGF-R2-positive but tumor rejection antigen 1-60 (TRA1-60)–negative population emerged. These VEGF-R2-positive but tumor rejection antigen 1-60–negative cells were also positive for platelet-derived growth factor receptor {alpha} and β chains and could be effectively differentiated into both VE-cadherin+ endothelial cell and {alpha}-smooth muscle actin+ mural cell. VE-cadherin+ cells, which were also CD34+ and VEGF-R2+ and thought to be endothelial cells in the early differentiation stage, could be expanded while maintaining their maturity. Their transplantation to the hindlimb ischemia model of immunodeficient mice contributed to the construction of new blood vessels and improved blood flow.

Conclusions— We could identify the differentiation process from human ES cells to vascular cell components and demonstrate that expansion and transplantation of vascular cells at the appropriate differentiation stage may constitute a novel strategy for vascular regenerative medicine.

We investigated differentiation kinetics of human ES cells to vascular cell components. We identified the differentiation process from human ES cells to endothelial cells and mural cells and demonstrated the potential of endothelial cells in the early differentiation stage as a cell source for vascular regeneration.


Key Words: angiogenesis • developmental biology • embryonic stem cells • vascular biology • endothelium




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. Taura, M. Sone, K. Homma, N. Oyamada, K. Takahashi, N. Tamura, S. Yamanaka, and K. Nakao
Induction and Isolation of Vascular Cells From Human Induced Pluripotent Stem Cells--Brief Report
Arterioscler. Thromb. Vasc. Biol., July 1, 2009; 29(7): 1100 - 1103.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Cimato, J. Beers, S. Ding, M. Ma, J. P. McCoy, M. Boehm, and E. G. Nabel
Neuropilin-1 Identifies Endothelial Precursors in Human and Murine Embryonic Stem Cells Before CD34 Expression
Circulation, April 28, 2009; 119(16): 2170 - 2178.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Cardiovasc DisHome page
K. Yamahara and H. Itoh
Potential use of endothelial progenitor cells for regeneration of the vasculature
Therapeutic Advances in Cardiovascular Disease, February 1, 2009; 3(1): 17 - 27.
[Abstract] [PDF]


Home page
CirculationHome page
G. Narazaki, H. Uosaki, M. Teranishi, K. Okita, B. Kim, S. Matsuoka, S. Yamanaka, and J. K. Yamashita
Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells
Circulation, July 29, 2008; 118(5): 498 - 506.
[Abstract] [Full Text] [PDF]